[Clinical evaluation of new cellulose acetate membranes for hemodialysis. Preliminary results].

R. Palla,F. Carmassi,A. Bionda,C. Donadio,E. Morelli,R. Bianchi,G. Mariani

1979-10-01

Abstract:

What problem does this paper attempt to address?

Takotsubo Syndrome: impact of medical therapies on prognosis. A state of art review

Ovidio De Filippo,Vanessa Peano,Marta Pasquero,Christian Templin,Victoria L. Cammann,Fabrizio D'Ascenzo,Gaetano Maria De Ferrari

DOI: https://doi.org/10.1016/j.cpcardiol.2024.102623

IF: 16.464

2024-05-08

Current Problems in Cardiology

Abstract:Tako-Tsubo Syndrome (TTS) presents as transient ventricular dysfunction, yet its underlying pathophysiology remains enigmatic. The prognosis of patients presenting with TTS appears to be impaired as compared to the general population and is similar to patients with acute coronary syndromes. Recent investigations have predominantly focused on elucidating therapeutic strategies associated with improved outcomes, particularly among post-menopausal female patients. Current evidence suggests that angiotensin-converting enzyme inhibitors (ACEi) may confer a survival advantage in TTS. Notably, ACEi emerges as the sole therapeutic modality demonstrating efficacy in both acute and chronic clinical courses of TTS. Despite this, the magnitude of survival benefit remains less pronounced than anticipated. This underscores the need for further research to explore additional therapeutic pathways and optimize management strategies for this unique patient cohort. Randomized clinical trials and meta-analysis are paramount in discerning the most effective therapeutic interventions aimed at enhancing survival and ameliorating outcomes in TTS. This review aims to comprehensively synthesize evidence pertaining to the prognostic implications of cardiovascular medications in TTS management.

cardiac & cardiovascular systems
Exploring Pathophysiological Mechanisms and Clinical Differences for a Personalized Approach in Patient Management

Simona Giubilato,Giuseppina Maura Francese,Maria Teresa Manes,Roberta Rossini,Roberta Della Bona,Laura Gatto,Antonio Di Monaco,Filippo Zilio,Nicola Gasparetto,Carlotta Sorini Dini,Francesco Borrello,Antonia Mannarini,Angela Beatrice Scardovi,Daniela Pavan,Francesco Amico,Giovanna Geraci,Carmine Riccio,Furio Colivicchi,Massimo Grimaldi,Michele Massimo Gulizia,Fabrizio Oliva

DOI: https://doi.org/10.3390/jcm13164925

IF: 3.9

2024-08-23

Journal of Clinical Medicine

Abstract:Takotsubo syndrome (TTS), also known as the broken-heart syndrome, is a reversible condition typically observed in female patients presenting for acute coronary syndromes (ACS). Despite its increasing incidence, TTS often remains undiagnosed due to its overlap with ACS. The pathophysiology of TTS is complex and involves factors such as coronary vasospasm, microcirculatory dysfunction, increased catecholamine levels, and overactivity of the sympathetic nervous system. Diagnosing TTS requires a comprehensive approach, starting with clinical suspicion and progressing to both non-invasive and invasive multimodal tests guided by a specific diagnostic algorithm. Management of TTS should be personalized, considering potential complications, the presence or absence of coronary artery disease (CAD), diagnostic test results, and the patient's clinical course. The current data primarily derive from case series, retrospective analyses, prospective registries, and expert opinions. In recent years, there has been growing recognition of gender differences in the pathophysiology, presentation, and outcomes of TTS. This review provides an updated overview of gender disparities, highlighting the importance of tailored diagnostic and management strategies.

medicine, general & internal
Epidemiology, Diagnosis, and Treatment of Takotsubo Syndrome: a Comprehensive Review

Xinyang Shou,Lingchun Lyu,Yucheng Wang,Zeyi Cheng,Yunchong Meng,Jun Chen,Kan Liu,Qiang Liu

DOI: https://doi.org/10.1097/cp9.0000000000000094

2024-01-01

Cardiology Plus

Abstract:Takotsubo syndrome (TTS) is characterized by apical or left ventricular (LV) ballooning and impaired wall motion as its primary features. Although women over 55 years make up the majority of TTS patients, male patients have a greater incidence of in-hospital mortality. TTS also impacts pregnant women and children, with conflicting information regarding racial differences. TTS has an in-hospital mortality rate comparable to that of acute ST-segment elevation myocardial infarction, and higher than that in patients with myocarditis. More than 10% of patients may experience a subsequent acute episode within 5 years after the initial event. TTS exhibits symptoms such as chest pain, electrocardiograph (ECG) abnormalities, elevated B-type natriuretic peptide (BNP), and N-terminal prohormone of brain natriuretic peptide (NT-pro-BNP) levels, and changes in several imaging approaches, which may aid in early diagnosis. Fluid resuscitation, β-blockers, angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), anti-anxiety or depression drugs, and cardiac rehabilitation may be employed to treat TTS, reduce recurrence rates, and improve functional exercise capacity and exercise time. After searching PubMed, Research Gate, Science Direct, and Web of Science, we summarized recent researches on epidemiology, diagnosis, treatments, and prognosis. These findings provide a theoretical basis for future clinical practice and will aid doctors and researchers investigating the unknown aspects of TTS.
Pathophysiology of Takotsubo Syndrome as A Bridge to Personalized Treatment

Monika Budnik,Radosław Piątkowski,Dorota Ochijewicz,Martyna Zaleska,Marcin Grabowski,Grzegorz Opolski

DOI: https://doi.org/10.3390/jpm11090879

2021-08-31

Abstract:Takotsubo syndrome (TTS) consists of transient dysfunction of the left and/or right ventricle in the absence of ruptured plaque; thrombus or vessel dissection. TTS may be divided into two categories. Primary TTS occurs when the cause of hospitalization is the symptoms resulting from damage to the myocardium usually preceded by emotional stress. Secondary TTS occurs in patients hospitalized for other medical; surgical; anesthetic; obstetric or psychiatric conditions who have activation of their sympathetic nervous system and catecholamines release- they develop TTS as a complication of their primary condition or its treatment. There are several hypotheses concerning the cause of the disease. They include a decrease in estrogen levels; microcirculation dysfunction; endothelial dysfunction and the hypothesis based on the importance of the brain-heart axis. More and more research concerns the importance of genetic factors in the development of the disease. To date; no effective treatment or prevention of recurrent TTS has been found. Only when the pathophysiology of the disease is fully known; then personalized treatment will be possible.
Left Ventricular Outflow Tract Obstruction/Hypertrophic Cardiomyopathy/Takotsubo Syndrome: A New Hypothesis of Takotsubo Syndrome Pathophysiology

John E. Madias

DOI: https://doi.org/10.1016/j.cpcardiol.2024.102668

IF: 16.464

2024-05-26

Current Problems in Cardiology

Abstract:The pathophysiology of TTS is still elusive. This viewpoint proposes that TTS is an acute coronary syndrome, engendered by an ASNS/catecholamine-induced LVOTO, which results in an enhanced wall stress and afterload-based supply/demand mismatch, culminating in a segmental myocardial ischemic injury state, in susceptible individuals. Such individuals are felt to be particularly women with chronic hypertension, known or latent HCM, or non-HCM segmental myocardial hypertrophy, and certain structural abnormalities involving the LV and the MV apparatus. Recommendations are provided to explore further this hypothesis, while maintaining our focus on all other advanced TTS pathophysiology hypotheses for all patients, or those who do not experience LVOTO, men, the young, and patients with reverse, mid-ventricular, or right ventricular TTS, in whom more prolonged hyperadrenergic stimulation and/or larger amounts of blood-ridden catecholamines, segmental particularities of cardiac innervation and/or density of α-, and β-adrenergic receptors, pheochromocytoma, neurological chronic or acute comorbidities/catastrophes, coronary epicardial/microvascular vasospasm, and CMD.

cardiac & cardiovascular systems
Acute loss of vision during pregnancy due to a suprasellar mass.

J. Kerrison,A. G. Lee,J. Weinstein

DOI: https://doi.org/10.1016/S0039-6257(97)00009-X

IF: 6.197

1997-03-01

Survey of Ophthalmology

Abstract:
Exploratory Review of the Takotsubo Syndrome and the Possible Role of the Psychosocial Stress Response and Inflammaging

Niklas Frank,Martin J. Herrmann,Martin Lauer,Carola Y. Förster

DOI: https://doi.org/10.3390/biom14020167

IF: 6.064

2024-01-31

Biomolecules

Abstract:Takotsubo syndrome (TTS) is a cardiomyopathy that clinically presents as a transient and reversible left ventricular wall motion abnormality (LVWMA). Recovery can occur spontaneously within hours or weeks. Studies have shown that it mainly affects older people. In particular, there is a higher prevalence in postmenopausal women. Physical and emotional stress factors are widely discussed and generally recognized triggers. In addition, the hypothalamic-pituitary-adrenal (HPA) axis and the associated glucocorticoid-dependent negative feedback play an important role in the resulting immune response. This review aims to highlight the unstudied aspects of the trigger factors of TTS. The focus is on emotional stress/chronic unpredictable mild stress (CUMS), which is influenced by estrogen concentration and noradrenaline, for example, and can lead to changes in the behavioral, hormonal, and autonomic systems. Age- and gender-specific aspects, as well as psychological effects, must also be considered. We hypothesize that this leads to a stronger corticosteroid response and altered feedback of the HPA axis. This may trigger proinflammatory markers and thus immunosuppression, inflammaging, and sympathetic overactivation, which contributes significantly to the development of TTS. The aim is to highlight the importance of CUMS and psychological triggers as risk factors and to make an exploratory proposal based on the new knowledge. Based on the imbalance between the sympathetic and parasympathetic nervous systems, transcutaneous vagus nerve stimulation (tVNS) is presented as a possible new therapeutic approach.

biochemistry & molecular biology
Epidemiology, pathogenesis, and management of takotsubo syndrome

Shams Y-Hassan,Per Tornvall

DOI: https://doi.org/10.1007/s10286-017-0465-z

2017-09-15

Clinical Autonomic Research

Abstract:Takotsubo syndrome is a recently recognized acute cardiac disease entity with a clinical presentation resembling that of an acute coronary syndrome. The typical takotsubo syndrome patient has a unique circumferential left (bi-) ventricular contraction abnormality profile that extends beyond a coronary artery supply territory and appears to follow the anatomical cardiac sympathetic innervation. The syndrome predominantly affects postmenopausal women and is often preceded by emotional or physical stress. Patients with predisposing factors such as malignancy and other chronic comorbidities are more prone to suffer from takotsubo syndrome. The pathogenesis of takotsubo syndrome is elusive. Several pathophysiological mechanisms involving myocardial ischemia (multivessel coronary artery spasm, microvascular dysfunction, aborted myocardial infarction), left ventricular outlet tract obstruction, blood-borne catecholamine myocardial toxicity, epinephrine-induced switch in signal trafficking, and autonomic nervous system dysfunction have been proposed. The syndrome is usually reversible; nevertheless, during the acute stage, a substantial number of patients develop severe complications such as arrhythmias, heart failure including pulmonary edema and cardiogenic shock, thromboembolism, cardiac arrest, and rupture. Treatment of precipitating factors, predisposing diseases, and complications is fundamental during the acute stage of the disease. The epidemiology, pathogenesis, and management of takotsubo syndrome are reviewed in this paper.

neurosciences,clinical neurology
Takotsubo Syndrome and Coronary Artery Disease: Which Came First—The Chicken or the Egg?

Mihail Celeski,Annunziata Nusca,Valeria Maria De Luca,Giorgio Antonelli,Valeria Cammalleri,Rosetta Melfi,Fabio Mangiacapra,Elisabetta Ricottini,Paolo Gallo,Nino Cocco,Raffaele Rinaldi,Francesco Grigioni,Gian Paolo Ussia

DOI: https://doi.org/10.3390/jcdd11020039

2024-01-26

Journal of Cardiovascular Development and Disease

Abstract:Takotsubo syndrome (TTS) is a clinical condition characterized by temporary regional wall motion anomalies and dysfunction that extend beyond a single epicardial vascular distribution. Various pathophysiological mechanisms, including inflammation, microvascular dysfunction, direct catecholamine toxicity, metabolic changes, sympathetic overdrive-mediated multi-vessel epicardial spasms, and transitory ischemia may cause the observed reversible myocardial stunning. Despite the fact that TTS usually has an acute coronary syndrome-like pattern of presentation, the absence of culprit atherosclerotic coronary artery disease is often reported at coronary angiography. However, the idea that coronary artery disease (CAD) and TTS conditions are mutually exclusive has been cast into doubt by numerous recent studies suggesting that CAD may coexist in many TTS patients, with significant clinical and prognostic repercussions. Whether the relationship between CAD and TTS is a mere coincidence or a bidirectional cause-and-effect is still up for debate, and misdiagnosis of the two disorders could lead to improper patient treatment with unfavourable outcomes. Therefore, this review seeks to provide a profound understanding of the relationship between CAD and TTS by analyzing potential common underlying pathways, addressing challenges in differential diagnosis, and discussing medical and procedural techniques to treat these conditions appropriately.

cardiac & cardiovascular systems
Cardiac autonomic dysfunction in Takotsubo cardiomyopathy: an observational study

F Hofer,F Theurl,T Dolejsi,K Tessadri,C Massmann,I Lechner,S J Reinstadler,M Schreinlechner,A Bauer

DOI: https://doi.org/10.1093/eurheartj/ehae666.1179

IF: 39.3

2024-10-30

European Heart Journal

Abstract:Takotsubo syndrome (TTS), commonly perceived as a benign and reversible condition has received attention due to emerging registry data revealing its prognosis to be comparable to acute coronary syndrome (ACS). Following ACS, a notable subset of patients develops autonomic dysfunction, whith unfavourable prognostic implications. Periodic repolarization dynamics (PRD) and deceleration capacity (DC), derived from ECG signals, are parameters capable of quantifying cardiac autonomic function. In this study, we aimed to assess autonomic dysfunction in patients with TTC in comparison to ST-elevation myocardial infarction (STEMI) patients. Consecutive patients diagnosed with TTS were prospectively recruited into an observational, single-centre cohort study. All patients underwent a 30-minute high-resolution ecg recording. Subsequent recordings were conducted at 4 and 12 months post-acute event. PRD and DC as markers for sympathetic and parasympathetic activity, respectively, were assessed using established methods. The control group comprised patients with STEMI. Statistical comparisons between groups were performed using the Mann-Whitney U-test, with a corrected significance level for multiple testing of α< .017. Between July 2021 and December 2023, 57 patients diagnosed with TTS were recruited (interquartile range [IQR]) 69.0 years (62.0-78.0), 98.3% women. A control group was derived from a pre-existing cohort of STEMI patients, matched through propensity score matching to adjust for age and sex (median age [IQR]: 69.0 [59.0-76.0] years, 98.3% women). At baseline, there was no significant difference in PRD between TTS patients and controls (median [IQR]: TTS: 5.28deg2 [3.43-9.93], STEMI: 4.40deg2 [2.24-7.21]; p = .04). However, at 4 months post-acute event, PRD was notably higher in TTS patients compared to controls (median [IQR]: TTS: 5.20deg2 [2.71-8.17], STEMI: 2.63deg2 [1.86-4.92]; p = .011). Interestingly, at 12-month follow-up, PRD in TTS patients did not differ from that of controls (median [IQR]: TTS: 4.55deg2 [2.89-8.40], STEMI: 4.15deg2 [2.42-6.85]; p = .68). Regarding DC, no significant differences were observed between TTS and STEMI patients at any time point (baseline: median [IQR]: TTS: 3.95 ms [2.27-5.51], STEMI: 3.52 ms [2.30-7.24], p = .51; 4 months: median [IQR]: TTS: 6.63 ms [4.59-8.64], STEMI: 7.41 ms [4.63-9.25], p = .39; 12 months: median [IQR]: TTS: 4.98 ms [4.19-6.67], STEMI: 7.48 ms [4.92-10.28], p = .17). Patients with TTS show substantial signs of cardiac autonomic dysfunction, similar or even higher than acute STEMI patients. This dysfunction persists even up to 4 months after the acute event, whereas STEMI patients show recovery of autonomic function in this 4 month period. DC remained consistent between TTS and STEMI patients across all time points. Further research elucidating the long-term implications of these autonomic alterations is warranted to refine risk stratification and therapeutic strategies in TTS management.

cardiac & cardiovascular systems
Noninvasive Assessment in Takotsubo Syndrome: A Diagnostic Challenge

Sara Amicone,Andrea Impellizzeri,Francesco Pio Tattilo,Khrystyna Ryabenko,Claudio Asta,Rebecca Belà,Nicole Suma,Lisa Canton,Damiano Fedele,Davide Bertolini,Francesca Bodega,Daniele Cavallo,Virginia Marinelli,Mariachiara Ciarlantini,Giuseppe Pastore,Ornella Di Iuorio,Marcello Casuso Alvarez,Leonardo Luca Bavuso,Jessica Salerno,Nicolò Vasumini,Angelo Maida,Matteo Armillotta,Francesco Angeli,Angelo Sansonetti,Luca Bergamaschi,Alberto Foà,Angelo Squeri,Gianni Dall'Ara,Carmine Pizzi

DOI: https://doi.org/10.1111/echo.15953

2024-10-12

Echocardiography

Abstract:A systematic diagnostic approach is crucial for accurate assessment in Takotsubo syndrome, given the diagnostic challenge. Multimodality noninvasive imaging is pivotal for a comprehensive evaluation. This encompasses echocardiography for acute complications and rapid identification of typical ventricular wall abnormalities, combined with cardiac magnetic resonance, which is increasingly recognized for the detection of characteristic myocardial oedema and for prognostic assessment. Coronary angiography with ventriculography may be reserved for cases with ST‐segment elevation, whereas in other scenarios, multimodality noninvasive imaging, including coronary‐CT, allows for prompt differentiation from other conditions, such as myocardial infarction and myocarditis, thus facilitating optimal management and improving outcomes. Takotsubo syndrome (TTS) is a clinical syndrome characterized by a transient left ventricular dysfunction whose diagnosis can be challenging due to its resemblance to acute myocardial infarction (AMI). Despite the growing recognition of TTS, acute complications and long‐term mortality rates are comparable to those observed in AMI patients. In this context, a systematic diagnostic approach is imperative for an accurate patient assessment, with due consideration of the distinctive characteristics and optimal timing of each imaging modality. Coronary angiography with ventriculography may be reserved for cases presenting with ST‐segment elevation, whereas in all other cases, the use of multimodality noninvasive imaging allows for a comprehensive evaluation of typical diagnostic features and detection of acute complications while also providing prognostic insights. The aim of this review is to evaluate the current research on non‐invasive modalities and to propose a diagnostic algorithm that will facilitate the identification and management of TTS.

cardiac & cardiovascular systems
Life-Threatening Arrhythmias in Patients With Takotsubo Syndrome: Insights Into Pathophysiology and Treatment Innovations

Giulia La Vecchia,Marco Giuseppe Del Buono,Tommaso Sanna,Pier Leopoldo Capecchi,Pietro Enea Lazzerini,Michele Golino,Jordana Kron,Paula Rodriguez-Miguelez,Gemma Pelargonio,Antonio Abbate

DOI: https://doi.org/10.1016/j.jacep.2024.03.034

Abstract:Takotsubo syndrome (TTS) is a reversible form of acute myocardial injury due to a neurocardiogenic mechanism associated with a relevant risk for life-threatening ventricular arrhythmias, occurring in up to 25% of all patients and including both ventricular arrhythmias (especially) in the context of QT prolongation and atrial tachy- or bradyarrhythmias. The pathogenetic mechanisms of TTS-related arrhythmic complications are not completely understood, and there are no randomized clinical trials addressing the pharmacologic and nonpharmacologic management in this specific setting. In this narrative review, the authors provide an overview of the pathogenesis and the therapeutic management of arrhythmic complications in patients with TTS, along with the future perspectives and the remaining knowledge gaps in this field.
[Takotsubo cardiomyopathy: current evidence from observational studies and pathophysiological background]

Francesco Santoro,Natale Daniele Brunetti,Nicola Tarantino,Riccardo Ieva,Matteo Di Biase,Luigi Di Biase

DOI: https://doi.org/10.1714/2464.25798

Abstract:Takotsubo cardiomyopathy is an acute reversible form of cardiac failure, firstly described in 1991, with a prognosis not favorable as previously thought. Although high levels of catecholamines have been suggested as the leading mechanism for the onset, the pathophysiology remains unclear. However, several pathophysiological explanations have been proposed, all not mutually exclusive. A complex chain of events is present, including the activation of the hypothalamic-pituitary-adrenal axis, the surge in circulating catecholamines and subsequent cardiovascular responses. This review addresses the diagnostic classification, short and mid-term prognosis, precipitating factors, classification into primary and secondary forms, and possible drug therapies for stress cardiomyopathy. Clinical and experimental studies are needed to further improve diagnosis and targeted therapies.
Takotsubo Syndrome (TTS) in Onco-Hematologic Patients: Retrospective Analysis and Focus on the Correlation or Not With Anticancer Drugs. Case Reports and Review of the Literature

Manlio Monti,Pietro Cortesi,Roberto Vespignani,Ilaria Bronico,Chiara Gallio,Michele Flospergher,Laura Matteucci,Giovanni Luca Frassineti

DOI: https://doi.org/10.3389/fonc.2022.875391

IF: 4.7

2022-05-27

Frontiers in Oncology

Abstract:Takotsubo syndrome (TTS) is an uncommon cardiovascular condition also known as stress-induced cardiomyopathy or broken heart disease. The syndrome, characterized by acute non-coronary segmental ventricular dysfunction, commonly occurs as a reaction to severe emotional or physical stress and can cause significant problems. Several classes of chemotherapeutic agents that are known to be cardiotoxic have been shown to be associated with TTS in cancer patients. Describing a case of TTS from chemotherapy and/or monoclonal antibody is important because these drugs are widely used and their temporary or permanent suspension could compromise the success of treatment. The detection and reporting of suspected adverse drug reactions in clinical practice are the foundations of postmarketing surveillance. We performed a retrospective analysis of a large number of patients followed at our cancer centre to identify drugs that could lead to the onset of TTS, focusing our attention on 2 monoclonal antibodies, bevacizumab and rituximab plus chemotherapy. A search was carried out for the word "Takotsubo" in database sources such as in PubMed, in medical oncology, radiology and cardiology electronic clinical records. From October 2007 to March 2021, of the 79,005 patients seen or treated for any kind of malignancy at our institute, 9 had a diagnosis of TTS (4 before and 5 after the diagnosis of malignancy). Only 2 patients had TTS after treatment with the anticancer drugs, bevacizumab and rituximab plus chemotherapy. These two patients were hospitalised, one for subocclusion while the other for pulmonary embolism (PE) with a life threatening condition and in need of intravenous catecholamines. For both patients, an ECG, echocardiography and coronary angiography were performed as well as blood tests with a subsequent diagnosis of TTS and both received cardiological treatment with resolution of the clinical picture. A reassessment of the two cases found that a subocclusion and intravenous catecholamines appeared to be the most likely triggers. In conclusion, TTS is rare in cancer patients. Identifying TTS triggers could be useful because it could induce therapeutic changes.

oncology
A contemporary update on cancer and takotsubo syndrome

Giacomo Tini,Luca Arcari,Raffaella Mistrulli,Federico Follesa,Alessandro Cianca,Matteo Sclafani,Giuliano Tocci,Paolo Spallarossa,Allegra Battistoni,Luca Cacciotti,Beatrice Musumeci,Emanuele Barbato

DOI: https://doi.org/10.3389/fcvm.2023.1301383

IF: 3.6

2024-01-09

Frontiers in Cardiovascular Medicine

Abstract:Takotsubo syndrome (TTS) is characterized by a transient left ventricular systolic dysfunction, burdened by significant acute and long-term mortality and morbidity. The prognosis of TTS, especially in the long-term, is influenced by both non-cardiovascular (non-CV) and CV comorbidities, among which cancer is one of the most common. The presence of a malignancy is proven to be associated with higher mortality in TTS. Moreover, a number of anticancer treatments has been reported to possibly cause TTS as a form of cardiotoxicity, even though clearcut associations are lacking. The aim of this narrative review is to sum up contemporary knowledge on the association of cancer and TTS, addressing unmet needs and practical implications. The importance of a close collaboration between cardiologists and oncologists is herein highlighted, both to allow an adequate management of the acute TTS phase, and to actively and safely return to the oncologic management once the acute setting is resolved.

cardiac & cardiovascular systems
Case report: Takotsubo syndrome following percutaneous coronary intervention

Rui Lu,Mingjun Lu,Shangfei He,Jing Lu,Yi Liao,Tongtao Cui,Min Wang

DOI: https://doi.org/10.1186/s13019-023-02412-0

2023-11-16

Journal of Cardiothoracic Surgery

Abstract:Abstract Background Takotsubo syndrome (TTS), which is frequently secondary to severe emotional (fear, anxiety, etc.) or physical stress, is an acute reversible heart failure syndrome characterized by temporary left ventricular regional systolic dysfunction. Nevertheless, TTS after percutaneous coronary intervention (PCI) is rare, and its clinical characteristics are easily confused with complications after PCI. Case presentation This article reports a case of TTS induced by psychological and physical pressure after successful PCI in our institution. The patient had symptoms comparable to complications after PCI, including V1-V5 ST segment elevation and T wave changes of electrocardiogram (ECG) and troponin elevation. Coronary angiogram, left ventricle opacification (LVO), and cardiac magnetic resonance (CMR) were performed to exclude postoperative complications. Diagnosis of TTS was eventually achieved. Conclusion We cannot dismiss the risk of TTS in patients who have unexplained V1-V5 ST segment elevation and T wave changes of ECG and troponin elevation following successful PCI. Meanwhile, medical personnel should provide mental, cultural, and emotional services to patients in addition to essential diagnostic and treatment technical services during the perioperative period.

surgery,cardiac & cardiovascular systems
Trends in Takotsubo syndrome

V Schweiger,V L Cammann,M Wuerdinger,T Gilhofer,D Niederseer,T F Luescher,F Ruschitzka,E Bossone,J R Ghadri,C Templin,D Di Vece

DOI: https://doi.org/10.1093/eurheartj/ehae666.1715

IF: 39.3

2024-10-28

European Heart Journal

Abstract:Background Previously considered a rare and relatively benign cardiac condition, Takotsubo syndrome (TTS) has undergone a significant shift in perception over the last two decades. This shift was mainly driven by results indicating that TTS is associated with signicant mortality and morbidity. Consequently, also the criteria for diagnosing TTS have been updated to reflect its recognition as a complex, multifactorial disease. Purpose The aim of the present study was to investigate trends in clinical presentation, demographics, and outcomes of patients with TTS. Methods The study analyzed 3,675 patients diagnosed with TTS from 2004 to 2021. Participants were divided into groups based on diagnosis, using three-year intervals, to perform trend analyses on demographics, risk factors, clinical presentations, and outcomes. The Cochran-Mantel-Haenszel test was used for categorical data trends, while the Mann-Kendall test assessed numerical variables. Mortality rates were compared using the log-rank test. Findings: The study period saw a steady increase in male patients (from 10% to 15%, p = 0.003). While apical TTS continued to be the most common type, the occurrence of midventricular TTS increased (from 18% to 37%, p = 0.002). Emotional triggers remained constant, whereas the prevalence of physical triggers significantly rose (from 35% to 50%, p = 0.034). The incidence of cardiogenic shock increased (from 11% to 20%, p=0.030), leading to a rise in in-hospital mortality rates (from 2% to 9%, p<0.001). A landmark analysis showed a significant increase in 60-day mortality rates (p < 0.001), but no difference in one-year mortality over the years (p = 0.140, Figure 1). Summary: This study of temporal trends in TTS highlights a shift in patients demographic with agrowing prevalence among males, increasing recognition of midventricular TTS type, and increased rates of cardiogenic shock and mortality in recent years. This shift aligns with the rising prevalence of physical triggers, as an expression of increased recognition of TTS in association with acute comorbidities.

cardiac & cardiovascular systems
Adult autoimmune enteropathy.

H. Freeman

DOI: https://doi.org/10.3748/WJG.14.1156

IF: 5.374

2008-02-28

World Journal of Gastroenterology

Abstract:Recent reports have suggested that autoimmune enteropathy involving the small bowel may occur in adults as well as in children. Apparently, the endoscopic and histological changes are similar to celiac disease before treatment, but these are not altered by any form of dietary restriction, including a gluten-free diet. As in celiac disease, histologic changes in gastric and colonic biopsies have also been recorded. Anti-enterocyte antibodies detected with immunofluorescent methods have been reported by a few laboratories, but these antibodies appear not to be specific and may simply represent epiphenomena. A widely available, reproducible and quantitative anti-enterocyte antibody assay is needed that could be applied in small bowel disorders that have the histological appearance of celiac disease, but fail to respond to a gluten-free diet.
Sympathetic nerve activity and response to physiological stress in Takotsubo syndrome

Christina Ekenbäck,Jonas Persson,Per Tornvall,Lena Forsberg,Jonas Spaak

DOI: https://doi.org/10.1007/s10286-024-01082-9

2024-11-23

Clinical Autonomic Research

Abstract:Purpose The prevailing hypothesis posits that Takotsubo syndrome (TTS) is caused by massive sympathetic activation, yet supporting evidence remains inconsistent. The objectives of the present study were to determine whether sympathetic activity and reactivity are enhanced in the recovery phase of TTS, and to evaluate the effect of selective β1-receptor blockade on sympathetic reactivity. Methods We conducted a case–control study that included 18 female patients with TTS and 13 age- and sex-matched controls. Muscle sympathetic nerve activity was measured through microneurography of the peroneal nerve at rest and during the cold pressor test. In the TTS group, recordings were repeated after randomisation to intravenous metoprolol or placebo. In 10 TTS patients, cardiac sympathetic activity was assessed using iodine 123-metaiodobenzylguanidine scintigraphy. Blood samples were collected during hospitalisation. Results Microneurography was performed a median of 27.5 days after patient admission. There were no significant differences in burst incidence, burst frequency, burst height or burst area between the TTS patients and the controls at rest, during stress or after administration of intravenous metoprolol. Iodine 123-metaiodobenzylguanidine scintigraphy was performed a median of 12.5 days after admission, revealing decreased early 1.54 ± 0.13 and late 1.40 ± 0.13 heart-to-mediastinum ratios, and an increased washout rate of 41.8 ± 12.1%. Catecholamine metabolites were comparable between the study groups. Conclusion General sympathetic hyperactivity or hyperreactivity unlikely contributes to TTS, as catecholamine levels and muscle sympathetic nerve activity at rest and during stress were similar between the TTS patients and the controls. As scintigraphy showed increased cardiac sympathetic activity, a pathological cardiac adrenergic response and vulnerability to sympathetic activation may be crucial for the development of the syndrome.

neurosciences,clinical neurology
[Protocol in Pap-class IIIA].

F. Lammes,H. Lamberts

1986-10-11

Abstract:

[Clinical evaluation of new cellulose acetate membranes for hemodialysis. Preliminary results].

Takotsubo Syndrome: impact of medical therapies on prognosis. A state of art review

Exploring Pathophysiological Mechanisms and Clinical Differences for a Personalized Approach in Patient Management

Epidemiology, Diagnosis, and Treatment of Takotsubo Syndrome: a Comprehensive Review

Pathophysiology of Takotsubo Syndrome as A Bridge to Personalized Treatment

Left Ventricular Outflow Tract Obstruction/Hypertrophic Cardiomyopathy/Takotsubo Syndrome: A New Hypothesis of Takotsubo Syndrome Pathophysiology

Acute loss of vision during pregnancy due to a suprasellar mass.

Exploratory Review of the Takotsubo Syndrome and the Possible Role of the Psychosocial Stress Response and Inflammaging

Epidemiology, pathogenesis, and management of takotsubo syndrome

Takotsubo Syndrome and Coronary Artery Disease: Which Came First—The Chicken or the Egg?

Cardiac autonomic dysfunction in Takotsubo cardiomyopathy: an observational study

Noninvasive Assessment in Takotsubo Syndrome: A Diagnostic Challenge

Life-Threatening Arrhythmias in Patients With Takotsubo Syndrome: Insights Into Pathophysiology and Treatment Innovations

[Takotsubo cardiomyopathy: current evidence from observational studies and pathophysiological background]

Takotsubo Syndrome (TTS) in Onco-Hematologic Patients: Retrospective Analysis and Focus on the Correlation or Not With Anticancer Drugs. Case Reports and Review of the Literature

A contemporary update on cancer and takotsubo syndrome

Case report: Takotsubo syndrome following percutaneous coronary intervention

Trends in Takotsubo syndrome

Adult autoimmune enteropathy.

Sympathetic nerve activity and response to physiological stress in Takotsubo syndrome

[Protocol in Pap-class IIIA].